Compare cornea surgery thickness results for FECD
Treatments studied
Part of Eyes & vision, Genetic & congenital clinical trials.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have FECD (cornea endothelium dysfunction) with only a few corneal “bumps” (guttata) that extend beyond about 4.5 mm
- Your cornea endothelium cell density is still fairly preserved (over 1000 cells per mm²) in at least one area of the cornea
- Your eye surgeon says you can safely have either study procedure
- You are able and willing to follow the study visit schedule and positioning instructions after surgery
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
This study looks at a specific type of cornea transplant (called endothelial lamellar transplant) for people with Fuchs disease or other causes of corneal swelling that affect vision. It aims to see whether this surgical approach improves outcomes and quality of life after surgery.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
This trial tests a new way to perform a corneal transplant (DSAEK) using a laser to prepare the donor tissue. It may help people with Fuchs' dystrophy or certain types of corneal swelling, but not those with glaucoma, scarring, or other eye diseases.
This trial tests an investigational eye drop (DT-168) in people with Fuchs endothelial corneal dystrophy who are already scheduled for a corneal transplant. The goal is to see if DT-168 can improve outcomes or delay the need for surgery.
Hear when a new Fuchs Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.